Home › Funds › Connor, Clark & Lunn Investment Management Ltd. › LLY

Connor, Clark & Lunn Investment Management Ltd. position in LLY

ELI LILLY & CO · Health Care

Connor, Clark & Lunn Investment Management Ltd. reported holding 173,392 shares of LLY (ELI LILLY & CO) in its Q2 2026 13F filing — a position valued at US$208.0M, representing 0.39% of its reported portfolio and ranking #49 among its reported holdings. Connor, Clark & Lunn Investment Management Ltd. has disclosed LLY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)173.39K sh
Reported value held$207.97M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Connor, Clark & Lunn Investment Management Ltd.'s LLY position evolved

Connor, Clark & Lunn Investment Management Ltd. first disclosed a stake in LLY in Q3 2023 at 110,715 shares (US$59.5M). The position peaked in Q1 2026 at 256,933 shares, worth US$236.3M. Across 12 filings, Connor, Clark & Lunn Investment Management Ltd. increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 173,392 shares valued at US$208.0M — a reduction of -83,541 shares quarter over quarter.. Notable position changes include a 49% trim in Q4 2024 (shares rose 7% over the following quarter), a 57% increase in Q4 2025 (shares fell 14% over the following quarter), a 234% increase in Q1 2026 (shares rose 30% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 110.72K $59.47M New
Q4 2023 65.08K $37.94M Reduce
Q1 2024 49.58K $38.57M Reduce
Q2 2024 54.40K $49.25M Add
Q3 2024 58.04K $51.42M Add
Q4 2024 29.33K $22.64M Reduce
Q1 2025 34.02K $28.10M Add
Q2 2025 42.07K $32.80M Add
Q3 2025 49.07K $37.44M Add
Q4 2025 76.90K $82.64M Add
Q1 2026 256.93K $236.32M Add
Q2 2026 173.39K $207.97M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LLY and 13F data

LLY (ELI LILLY & CO) is a Health Care company. 38 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), BlackRock Inc (US$81.01B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LLY

All LLY fund holders →

FAQ

How long has Connor, Clark & Lunn Investment Management Ltd. held LLY?

Connor, Clark & Lunn Investment Management Ltd. has disclosed LLY holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Connor, Clark & Lunn Investment Management Ltd.'s current position in LLY?

As of Q2 2026, Connor, Clark & Lunn Investment Management Ltd. holds 173.39K shares of LLY (ELI LILLY & CO), valued at $207.97M, representing 0.39% of its reported portfolio and ranking #49.

Has Connor, Clark & Lunn Investment Management Ltd. been buying or selling LLY?

In the latest 13F filing (Q2 2026), Connor, Clark & Lunn Investment Management Ltd. reduced its position in LLY. The position peaked in Q1 2026 at 256.93K shares.

Which other funds hold LLY?

Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, BlackRock Inc, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.